Showing results (1-10 of 228) with videos related to
Sort By:
Pageof 23
Current Opinion in Nephrology and Hypertension|April 18, 2009
Mechanisms for increased cardiovascular disease in chronic kidney dysfunctionSuguru Yamamoto, Valentina KonClinical and Experimental Nephrology|September 11, 2013
Chronic kidney disease induced dysfunction of high density lipoproteinSuguru Yamamoto, Valentina KonAtherosclerosis|July 18, 2015
Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotypeSuguru Yamamoto, Jiayong Zhong, Patricia G Yancey, et al.Clinical Calcium|July 28, 2018
[Fragility Fractures in Hemodialysis Patients. Uremic toxins-related abnormal bone metabolism.]Suguru YamamotoClinical and Experimental Nephrology|June 6, 2018
Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β2-microglobulin-related amyloidosis and indoxyl sulfate-induced atherosclerosis-Oshima Award Address 2016Suguru YamamotoArteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2011
Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosisSuguru Yamamoto, Patricia G Yancey, Yiqin Zuo, et al.Current Opinion in Nephrology and Hypertension|April 10, 2004
Angiotensin in atherosclerosisValentina Kon, Kathy JabsBiochimica Et Biophysica Acta|October 18, 2005
Historical background and clinical treatment of dialysis-related amyloidosisSuguru Yamamoto, Fumitake GejyoNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 20, 2011
Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient miceSuguru Yamamoto, Yiqin Zuo, Ji Ma, et al.Pageof 23